Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

SURVIVAL AND KIDNEY TRANSPLANT INCIDENCE ON HOME VERSUS IN-CENTER HEMODIALYSIS, FOLLOWING PERITONEAL DIALYSIS TECHNIQUE FAILURE.

Kansal SK, Morfin JA, Weinhandl ED.

Perit Dial Int. 2018 Jul 31. pii: pdi.2017.00207. doi: 10.3747/pdi.2017.00207. [Epub ahead of print]

PMID:
30065065
2.

Drug Therapy Problem Severity Following Hospitalization and Association With 30-Day Clinical Outcomes.

Westberg SM, Yarbrough A, Weinhandl ED, Adam TJ, Brummel AR, Reidt SL, Sick BT, St Peter WL.

Ann Pharmacother. 2018 Jun 1:1060028018781919. doi: 10.1177/1060028018781919. [Epub ahead of print]

PMID:
29888615
3.

Relative risk of home hemodialysis attrition in patients using a telehealth platform.

Weinhandl ED, Collins AJ.

Hemodial Int. 2017 Dec 6. doi: 10.1111/hdi.12621. [Epub ahead of print]

PMID:
29210164
4.

Phosphate-Binder Use in US Dialysis Patients: Prevalence, Costs, Evidence, and Policies.

St Peter WL, Wazny LD, Weinhandl ED.

Am J Kidney Dis. 2018 Feb;71(2):246-253. doi: 10.1053/j.ajkd.2017.09.007. Epub 2017 Nov 28.

PMID:
29195858
5.

Erratum to: A Review of Phosphate Binders in Chronic Kidney Disease: Incremental Progress or Just Higher Costs?

St Peter WL, Wazny LD, Weinhandl E, Cardone KE, Hudson JQ.

Drugs. 2017 Sep;77(14):1611. doi: 10.1007/s40265-017-0798-x. No abstract available.

PMID:
28786038
6.

A Review of Phosphate Binders in Chronic Kidney Disease: Incremental Progress or Just Higher Costs?

St. Peter WL, Wazny LD, Weinhandl E, Cardone KE, Hudson JQ.

Drugs. 2017 Jul;77(11):1155-1186. doi: 10.1007/s40265-017-0758-5. Review. Erratum in: Drugs. 2017 Aug 7;:. Peter, Wendy L St [corrected to St. Peter, Wendy L].

PMID:
28584909
7.

Small airway function before and after cold dry air challenge in pediatric asthma patients during remission.

Steinbacher M, Pfleger A, Schwantzer G, Jauk S, Weinhandl E, Eber E.

Pediatr Pulmonol. 2017 Jul;52(7):873-879. doi: 10.1002/ppul.23724. Epub 2017 May 9.

PMID:
28486753
8.

Relative Incidence of Acute Adverse Events with Ferumoxytol Compared to Other Intravenous Iron Compounds: A Matched Cohort Study.

Wetmore JB, Weinhandl ED, Zhou J, Gilbertson DT.

PLoS One. 2017 Jan 30;12(1):e0171098. doi: 10.1371/journal.pone.0171098. eCollection 2017.

9.

Intensive Hemodialysis and Potential Risks With Increasing Treatment.

Kraus MA, Kansal S, Copland M, Komenda P, Weinhandl ED, Bakris GL, Chan CT, Fluck RJ, Burkart JM.

Am J Kidney Dis. 2016 Nov;68(5S1):S51-S58. doi: 10.1053/j.ajkd.2016.05.020. Review.

PMID:
27772644
10.

Intensive Hemodialysis, Left Ventricular Hypertrophy, and Cardiovascular Disease.

McCullough PA, Chan CT, Weinhandl ED, Burkart JM, Bakris GL.

Am J Kidney Dis. 2016 Nov;68(5S1):S5-S14. doi: 10.1053/j.ajkd.2016.05.025. Review.

PMID:
27772643
11.

Intensive Hemodialysis and Treatment Complications and Tolerability.

Morfin JA, Fluck RJ, Weinhandl ED, Kansal S, McCullough PA, Komenda P.

Am J Kidney Dis. 2016 Nov;68(5S1):S43-S50. doi: 10.1053/j.ajkd.2016.05.021. Review.

PMID:
27772642
12.

Intensive Hemodialysis and Health-Related Quality of Life.

Kraus MA, Fluck RJ, Weinhandl ED, Kansal S, Copland M, Komenda P, Finkelstein FO.

Am J Kidney Dis. 2016 Nov;68(5S1):S33-S42. doi: 10.1053/j.ajkd.2016.05.023. Review.

PMID:
27772641
13.

Intensive Hemodialysis, Mineral and Bone Disorder, and Phosphate Binder Use.

Copland M, Komenda P, Weinhandl ED, McCullough PA, Morfin JA.

Am J Kidney Dis. 2016 Nov;68(5S1):S24-S32. doi: 10.1053/j.ajkd.2016.05.024. Review.

PMID:
27772640
14.

Intensive Hemodialysis, Blood Pressure, and Antihypertensive Medication Use.

Bakris GL, Burkart JM, Weinhandl ED, McCullough PA, Kraus MA.

Am J Kidney Dis. 2016 Nov;68(5S1):S15-S23. doi: 10.1053/j.ajkd.2016.05.026. Review.

PMID:
27772639
15.

Controlling confounding of treatment effects in administrative data in the presence of time-varying baseline confounders.

Gilbertson DT, Bradbury BD, Wetmore JB, Weinhandl ED, Monda KL, Liu J, Brookhart MA, Gustafson SK, Roberts T, Collins AJ, Rothman KJ.

Pharmacoepidemiol Drug Saf. 2016 Mar;25(3):269-77. doi: 10.1002/pds.3922. Epub 2015 Nov 26.

PMID:
26608680
16.

Mortality, Hospitalization, and Technique Failure in Daily Home Hemodialysis and Matched Peritoneal Dialysis Patients: A Matched Cohort Study.

Weinhandl ED, Gilbertson DT, Collins AJ.

Am J Kidney Dis. 2016 Jan;67(1):98-110. doi: 10.1053/j.ajkd.2015.07.014. Epub 2015 Aug 28.

17.

Comorbidity ascertainment from the ESRD Medical Evidence Report and Medicare claims around dialysis initiation: a comparison using US Renal Data System data.

Krishnan M, Weinhandl ED, Jackson S, Gilbertson DT, Lacson E Jr.

Am J Kidney Dis. 2015 Nov;66(5):802-12. doi: 10.1053/j.ajkd.2015.04.015. Epub 2015 May 23.

PMID:
26015277
18.

Peer kidney care initiative 2014 report: dialysis care and outcomes in the United States.

Weinhandl E, Constantini E, Everson S, Gilbertson D, Li S, Solid C, Anger M, Bhat JG, DeOreo P, Krishnan M, Nissenson A, Johnson D, Ikizler TA, Maddux F, Sadler J, Tyshler L, Parker T 3rd, Schiller B, Smith B, Lindenfeld S, Collins AJ.

Am J Kidney Dis. 2015 Jun;65(6 Suppl 1):Svi, S1-140. doi: 10.1053/j.ajkd.2015.03.021. No abstract available.

PMID:
26003780
19.

Short-term effects of physiotherapy on ventilation inhomogeneity in cystic fibrosis patients with a wide range of lung disease severity.

Pfleger A, Steinbacher M, Schwantzer G, Weinhandl E, Wagner M, Eber E.

J Cyst Fibros. 2015 Sep;14(5):627-31. doi: 10.1016/j.jcf.2014.12.017. Epub 2015 Jan 19.

20.

Hospitalization in daily home hemodialysis and matched thrice-weekly in-center hemodialysis patients.

Weinhandl ED, Nieman KM, Gilbertson DT, Collins AJ.

Am J Kidney Dis. 2015 Jan;65(1):98-108. doi: 10.1053/j.ajkd.2014.06.015. Epub 2014 Jul 29.

PMID:
25085647
21.

Relative safety of peginesatide and epoetin alfa.

Weinhandl ED, Gilbertson DT, Collins AJ, Foley RN.

Pharmacoepidemiol Drug Saf. 2014 Oct;23(10):1003-11. doi: 10.1002/pds.3655. Epub 2014 Jun 6.

PMID:
24905967
22.

Excluding the typical patient: thirty years of pharmacotherapy efficacy trials for obsessive-compulsive disorder.

Odlaug BL, Weinhandl E, Mancebo MC, Mortensen EL, Eisen JL, Rasmussen SA, Schreiber LR, Grant JE.

Ann Clin Psychiatry. 2014 Feb;26(1):39-46. Review.

23.

Comparative effectiveness of calcium acetate and sevelamer on clinical outcomes in elderly hemodialysis patients enrolled in Medicare part D.

Yusuf AA, Weinhandl ED, St Peter WL.

Am J Kidney Dis. 2014 Jul;64(1):95-103. doi: 10.1053/j.ajkd.2013.11.015. Epub 2013 Dec 31.

24.

US Renal Data System 2013 Annual Data Report.

Collins AJ, Foley RN, Chavers B, Gilbertson D, Herzog C, Ishani A, Johansen K, Kasiske BL, Kutner N, Liu J, St Peter W, Guo H, Hu Y, Kats A, Li S, Li S, Maloney J, Roberts T, Skeans M, Snyder J, Solid C, Thompson B, Weinhandl E, Xiong H, Yusuf A, Zaun D, Arko C, Chen SC, Daniels F, Ebben J, Frazier E, Johnson R, Sheets D, Wang X, Forrest B, Berrini D, Constantini E, Everson S, Eggers P, Agodoa L.

Am J Kidney Dis. 2014 Jan;63(1 Suppl):A7. doi: 10.1053/j.ajkd.2013.11.001. Review. No abstract available.

PMID:
24360288
25.

The authors reply.

Liu J, Weinhandl ED, Collins AJ, St Peter WL.

Kidney Int. 2013 Nov;84(5):1053. doi: 10.1038/ki.2013.261. No abstract available.

26.

In reply to 'Primary objective of study of sitagliptin in patients with ESRD on dialysis'.

St Peter WL, Weinhandl ED, Flessner MF.

Am J Kidney Dis. 2013 Sep;62(3):642-3. doi: 10.1053/j.ajkd.2013.06.009. No abstract available.

PMID:
23972059
27.

Clinical outcomes associated with receipt of integrated pharmacy services by hemodialysis patients: a quality improvement report.

Weinhandl ED, Arneson TJ, St Peter WL.

Am J Kidney Dis. 2013 Sep;62(3):557-67. doi: 10.1053/j.ajkd.2013.02.360. Epub 2013 Apr 16.

PMID:
23597860
28.

Longitudinal course of pharmacotherapy in obsessive-compulsive disorder.

Grant JE, Mancebo MC, Weinhandl E, Odlaug BL, Eisen JL, Rasmussen SA.

Int Clin Psychopharmacol. 2013 Jul;28(4):200-5. doi: 10.1097/YIC.0b013e3283613e4d.

29.

Sitagliptin--another option for managing type 2 diabetes in dialysis patients?

St Peter WL, Weinhandl ED, Flessner MF.

Am J Kidney Dis. 2013 Apr;61(4):532-5. doi: 10.1053/j.ajkd.2013.01.004. No abstract available.

PMID:
23497767
30.

US Renal Data System 2012 Annual Data Report.

Collins AJ, Foley RN, Herzog C, Chavers B, Gilbertson D, Herzog C, Ishani A, Johansen K, Kasiske B, Kutner N, Liu J, St Peter W, Ding S, Guo H, Kats A, Lamb K, Li S, Li S, Roberts T, Skeans M, Snyder J, Solid C, Thompson B, Weinhandl E, Xiong H, Yusuf A, Zaun D, Arko C, Chen SC, Daniels F, Ebben J, Frazier E, Hanzlik C, Johnson R, Sheets D, Wang X, Forrest B, Constantini E, Everson S, Eggers P, Agodoa L.

Am J Kidney Dis. 2013 Jan;61(1 Suppl 1):A7, e1-476. doi: 10.1053/j.ajkd.2012.11.031. No abstract available.

PMID:
23253259
31.

Estimated number of prevalent cases of metastatic bone disease in the US adult population.

Li S, Peng Y, Weinhandl ED, Blaes AH, Cetin K, Chia VM, Stryker S, Pinzone JJ, Acquavella JF, Arneson TJ.

Clin Epidemiol. 2012;4:87-93. doi: 10.2147/CLEP.S28339. Epub 2012 Apr 10.

32.

Sources of drug coverage among Medicare beneficiaries with ESRD.

Howell BL, Powers CA, Weinhandl ED, St Peter WL, Frankenfield DL.

J Am Soc Nephrol. 2012 May;23(5):959-65. doi: 10.1681/ASN.2011070740. Epub 2012 Mar 8.

33.

Survival in daily home hemodialysis and matched thrice-weekly in-center hemodialysis patients.

Weinhandl ED, Liu J, Gilbertson DT, Arneson TJ, Collins AJ.

J Am Soc Nephrol. 2012 May;23(5):895-904. doi: 10.1681/ASN.2011080761. Epub 2012 Feb 23.

34.

Generalization of trim and fill for application in meta-regression.

Weinhandl ED, Duval S.

Res Synth Methods. 2012 Mar;3(1):51-67. doi: 10.1002/jrsm.1042.

PMID:
26061999
35.

Correcting for Publication Bias in the Presence of Covariates [Internet].

Duval S, Weinhandl E.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2011 Sep.

36.

Utilization and costs of cardiovascular disease medications in dialysis patients in Medicare Part D.

Frankenfield DL, Weinhandl ED, Powers CA, Howell BL, Herzog CA, St Peter WL.

Am J Kidney Dis. 2012 May;59(5):670-81. doi: 10.1053/j.ajkd.2011.10.047. Epub 2011 Dec 28.

PMID:
22206743
37.

'United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States.

Collins AJ, Foley RN, Chavers B, Gilbertson D, Herzog C, Johansen K, Kasiske B, Kutner N, Liu J, St Peter W, Guo H, Gustafson S, Heubner B, Lamb K, Li S, Li S, Peng Y, Qiu Y, Roberts T, Skeans M, Snyder J, Solid C, Thompson B, Wang C, Weinhandl E, Zaun D, Arko C, Chen SC, Daniels F, Ebben J, Frazier E, Hanzlik C, Johnson R, Sheets D, Wang X, Forrest B, Constantini E, Everson S, Eggers P, Agodoa L.

Am J Kidney Dis. 2012 Jan;59(1 Suppl 1):A7, e1-420. doi: 10.1053/j.ajkd.2011.11.015. No abstract available.

PMID:
22177944
38.

Issues regarding 'immortal time' in the analysis of the treatment effects in observational studies.

Liu J, Weinhandl ED, Gilbertson DT, Collins AJ, St Peter WL.

Kidney Int. 2012 Feb;81(4):341-50. doi: 10.1038/ki.2011.388. Epub 2011 Nov 16. Review.

39.

Association of mean weekly epoetin alfa dose with mortality risk in a retrospective cohort study of Medicare hemodialysis patients.

Weinhandl ED, Gilbertson DT, Collins AJ.

Am J Nephrol. 2011;34(4):298-308. doi: 10.1159/000330693. Epub 2011 Aug 9.

PMID:
21829009
40.

Invalid sampling in a validation study of diagnosis codes for infection.

Weinhandl ED, Gilbertson DT.

J Clin Epidemiol. 2011 May;64(5):574-5; author reply 573. doi: 10.1016/j.jclinepi.2010.11.006. Epub 2011 Feb 16. No abstract available.

PMID:
21324646
41.

US Renal Data System 2010 Annual Data Report.

Collins AJ, Foley RN, Herzog C, Chavers B, Gilbertson D, Ishani A, Kasiske B, Liu J, Mau LW, McBean M, Murray A, St Peter W, Guo H, Gustafson S, Li Q, Li S, Li S, Peng Y, Qiu Y, Roberts T, Skeans M, Snyder J, Solid C, Wang C, Weinhandl E, Zaun D, Arko C, Chen SC, Dalleska F, Daniels F, Dunning S, Ebben J, Frazier E, Hanzlik C, Johnson R, Sheets D, Wang X, Forrest B, Constantini E, Everson S, Eggers P, Agodoa L.

Am J Kidney Dis. 2011 Jan;57(1 Suppl 1):A8, e1-526. doi: 10.1053/j.ajkd.2010.10.007. No abstract available.

PMID:
21184928
42.

Hemoglobin variability and mortality: confounding by disease severity.

Weinhandl ED, Peng Y, Gilbertson DT, Bradbury BD, Collins AJ.

Am J Kidney Dis. 2011 Feb;57(2):255-65. doi: 10.1053/j.ajkd.2010.06.013.

PMID:
20801571
43.

A simple tool to predict outcomes after kidney transplant.

Kasiske BL, Israni AK, Snyder JJ, Skeans MA, Peng Y, Weinhandl ED.

Am J Kidney Dis. 2010 Nov;56(5):947-60. doi: 10.1053/j.ajkd.2010.06.020.

PMID:
20801565
44.

Predicting coronary heart disease after kidney transplantation: Patient Outcomes in Renal Transplantation (PORT) Study.

Israni AK, Snyder JJ, Skeans MA, Peng Y, Maclean JR, Weinhandl ED, Kasiske BL; PORT Investigators.

Am J Transplant. 2010 Feb;10(2):338-53. doi: 10.1111/j.1600-6143.2009.02949.x.

45.

Excerpts from the US Renal Data System 2009 Annual Data Report.

Collins AJ, Foley RN, Herzog C, Chavers BM, Gilbertson D, Ishani A, Kasiske BL, Liu J, Mau LW, McBean M, Murray A, St Peter W, Guo H, Li Q, Li S, Li S, Peng Y, Qiu Y, Roberts T, Skeans M, Snyder J, Solid C, Wang C, Weinhandl E, Zaun D, Arko C, Chen SC, Dalleska F, Daniels F, Dunning S, Ebben J, Frazier E, Hanzlik C, Johnson R, Sheets D, Wang X, Forrest B, Constantini E, Everson S, Eggers PW, Agodoa L.

Am J Kidney Dis. 2010 Jan;55(1 Suppl 1):S1-420, A6-7. doi: 10.1053/j.ajkd.2009.10.009. No abstract available.

46.

Propensity-matched mortality comparison of incident hemodialysis and peritoneal dialysis patients.

Weinhandl ED, Foley RN, Gilbertson DT, Arneson TJ, Snyder JJ, Collins AJ.

J Am Soc Nephrol. 2010 Mar;21(3):499-506. doi: 10.1681/ASN.2009060635. Epub 2010 Feb 4.

47.

Economic evaluation of sevelamer versus calcium-based phosphate binders in hemodialysis patients: a secondary analysis using centers for Medicare & Medicaid services data.

St Peter WL, Fan Q, Weinhandl E, Liu J.

Clin J Am Soc Nephrol. 2009 Dec;4(12):1954-61. doi: 10.2215/CJN.04100609. Epub 2009 Oct 15.

48.

Racial disparity trends for graft failure in the US pediatric kidney transplant population, 1980-2004.

Chavers BM, Snyder JJ, Skeans MA, Weinhandl ED, Kasiske BL.

Am J Transplant. 2009 Mar;9(3):543-9. doi: 10.1111/j.1600-6143.2008.02530.x.

49.

Effect of comorbidity adjustment on CMS criteria for kidney transplant center performance.

Weinhandl ED, Snyder JJ, Israni AK, Kasiske BL.

Am J Transplant. 2009 Mar;9(3):506-16. doi: 10.1111/j.1600-6143.2008.02527.x. Epub 2009 Feb 3. Erratum in: Am J Transplant. 2009 Nov;9(11):2646.

50.

United States Renal Data System 2008 Annual Data Report.

Collins AJ, Foley RN, Herzog C, Chavers B, Gilbertson D, Ishani A, Kasiske B, Liu J, Mau LW, McBean M, Murray A, St Peter W, Guo H, Li Q, Li S, Li S, Peng Y, Qiu Y, Roberts T, Skeans M, Snyder J, Solid C, Wang C, Weinhandl E, Zaun D, Arko C, Chen SC, Dalleska F, Daniels F, Dunning S, Ebben J, Frazier E, Hanzlik C, Johnson R, Sheets D, Wang X, Forrest B, Constantini E, Everson S, Eggers P, Agodoa L.

Am J Kidney Dis. 2009 Jan;53(1 Suppl):S1-374. doi: 10.1053/j.ajkd.2008.10.005. No abstract available.

PMID:
19111206

Supplemental Content

Loading ...
Support Center